NDLI: Carcinogenesis of PIK3CA

Content Provider	Springer Nature : BioMed Central
Author	German, Sidra Aslam, Hafiz Muhammad Saleem, Shafaq Raees, Aisha Anum, Tooba Alvi, Arsalan Ahmad Haseeb, Abdul
Abstract	PIK3CA is the most frequently mutated oncogene in human cancers. PIK3CA is phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha. It controls cell growth, proliferation, motility, survival, differentiation and intracellular trafficking. In most of human cancer alteration occurred frequently in the alpha isoform of phosphatidylinositol 3 kinase. PIK3CA mutations were most frequent in endometrial, ovarian, colorectal, breast, cervical, squamous cell cancer of the head and neck, chondroma, thyroid carcinoma and in cancer family syndrome. Inhibition of PI3K signaling can diminish cell proliferation, and in some circumstances, promote cell death. Consequently, components of this pathway present attractive targets for cancer therapeutics. A number of PI3K pathway inhibitors have been developed and used. PI3K inhibitors (both pan-PI3K and isoform-specific PI3K inhibitors), dual PI3K-mTOR inhibitors that are catalytic site inhibitors of the p110 isoforms and mTOR (the kinase component of both mTORC1 and mTORC2), mTOR catalytic site inhibitors, and AKT inhibitors are the most advanced in the clinic. They are approved for the treatment of several carcinomas.
Related Links	https://hccpjournal.biomedcentral.com/counter/pdf/10.1186/1897-4287-11-5.pdf
Ending Page	3
Page Count	3
Starting Page	1
File Format	HTM / HTML
ISSN	18974287
DOI	10.1186/1897-4287-11-5
Journal	Hereditary Cancer in Clinical Practice
Issue Number	1
Volume Number	11
Language	English
Publisher	BioMed Central
Publisher Date	2013-06-15
Access Restriction	Open
Subject Keyword	Cancer Research Oncology Human Genetics Thyroid Carcinoma Papillary Thyroid Carcinoma Familial Adenomatous Polyposis PIK3CA Mutation Anaplastic Thyroid Cancer
Content Type	Text
Subject	Genetics (clinical) Oncology
Journal Impact Factor	2/2023
5-Year Journal Impact Factor	1.9/2023

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Thyroid cancer complicating familial adenomatous polyposis: mutation spectrum of at-risk individuals

Thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis (FAP): Memorial Sloan-Kettering Cancer Center (MSKCC) registry experience

Papillary thyroid cancer in a patient with MUTYH-associated polyposis (MAP)

Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposis

Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP

Case report: metachronous central nervous system desmoid tumours and thyroid carcinoma in a young familial adenomatous polyposis patient

Drug therapy for hereditary cancers

The case of the youngest infant with hepatoblastoma with APC gene mutation

Familial Adenomatous Polyposis (FAP) and Other Polyposis Syndromes

Carcinogenesis of PIK3CA

Similar Documents

Thyroid cancer complicating familial adenomatous polyposis: mutation spectrum of at-risk individuals

Thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis (FAP): Memorial Sloan-Kettering Cancer Center (MSKCC) registry experience

Papillary thyroid cancer in a patient with MUTYH-associated polyposis (MAP)

Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposis

Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP

Case report: metachronous central nervous system desmoid tumours and thyroid carcinoma in a young familial adenomatous polyposis patient

Drug therapy for hereditary cancers

The case of the youngest infant with hepatoblastoma with APC gene mutation

Familial Adenomatous Polyposis (FAP) and Other Polyposis Syndromes

Carcinogenesis of PIK3CA